Zepp Health Corporation shares fall 4.76% in after-hours after reporting 30% revenue growth forecast for Q2 2025 and positive reviews for new products.

Zepp Health Corporation surged 4.76% in after-hours trading, driven by the company's forecast of a 30% revenue growth for the second quarter of 2025, its first increase in three years, and a strategic shift towards its own brand Amazfit, which saw a 10% year-over-year revenue increase and a 37.3% gross margin in the first quarter of 2025. Additionally, the company's new products, Amazfit Active 2 and Bip 6, have received positive reviews and boosted sales.